Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07226596

Non-Abstinence Outcomes in Methamphetamine Use Disorder

Advancing Non-Abstinence Outcomes in the Treatment of Methamphetamine Use Disorder

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
William Stoops · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Reduced drug use is a clinically meaningful target for treatment development, but few studies have evaluated the positive impacts produced by this behavioral change, preventing adoption of this endpoint in clinical trials. The proposed research will fill that critical knowledge gap by demonstrating the biopsychosocial benefits of reduced methamphetamine use. These data will be used to change current accepted methamphetamine treatment endpoints and accelerate identification of therapies for methamphetamine use disorder.

Conditions

Interventions

TypeNameDescription
BEHAVIORALContingency ManagementSubjects will receive payments for providing methamphetamine negative urine samples.

Timeline

Start date
2026-01-14
Primary completion
2031-01-04
Completion
2031-01-04
First posted
2025-11-10
Last updated
2026-01-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07226596. Inclusion in this directory is not an endorsement.